25 healthy individuals. This study was approved by the local ethics committee, and all patients gave written informed consent. As shown in Figure 1 , none of these cytokines was elevated in patients with IPAH; patients with APAH, however, had significantly elevated serum levels of TNF-␣ but not of IL-1 and IL-6.
Response

To the Editor:
We appreciate the thoughtful comments by Hoeper and Welte on our article in CHEST (August 2006) 1 demonstrating that elevated pulmonary artery pressure in COPD is associated with increases in C-reactive protein (CRP) and tumor necrosis factor (TNF)-␣ levels. We fully agree that there are several limitations to our study that were discussed in depth in the original article. 1 Importantly, in view of the cross-sectional character of the data, our results should be considered as hypotheses generating. Indeed, Sin and Man 2 underline that it is a challenge for the COPD research community to determine, through well-designed clinical and animal studies, the validity of the hypothesis that systemic inflammation may be involved in the pathogenesis of pulmonary hypertension. Hoeper and Welte provide us with interesting observations of no increases of interleukin (IL)-1, IL-6, or TNF-␣ in patients with idiopathic pulmonary arterial hypertension compared to healthy individuals. However, TNF-␣ but not IL-1 and IL-6 were increased in patients with pulmonary arterial hypertension associated with connective tissue disease. These data do not contradict our results in any way. First, we have studied a different population of patients; second, Hoeper and Welte did not assess serum CRP in their study. Importantly, our main result was that Pao 2 and log-CRP levels were the only two significant predictors of systolic pulmonary artery pressure. This finding is meaningful especially in the light of recently published studies indicating that CRP levels correlate with 6-min walk distance 3 and, in addition, relate to mortality in COPD patients. 4 Nevertheless, valuable data of Hoeper and Welte emphasize the need to publish also negative results in scientific journals. Only by doing so can the scientific community gain a complex picture of the studied medical field. 
Treating Critically Ill Patients With Sugar Pills
To the Editor:
It surprises me that CHEST would publish an article (March 2005) 1 on the effect of a therapeutic agent when in fact the patients received none of the agent mentioned in the title of the article. It is not mentioned in the title, but reading the article reveals that the "potassium dichromate" was a homeopathic C30 dilution. That is a dilution by a factor of 10 60 , and for those of us who believe in the Avogadro number, that means there would be one molecule in a sphere with a diameter of approximately 1.46 ϫ 10 11 m. That is close to the distance from the earth to the sun. To describe this as "diluted and well shaken," as the authors do, is the understatement of the century. The fact of the matter is that the medicine contained no medicine.
The authors 1 will doubtless claim some magic effect of shaking that causes the water to remember for years that it once had some dichromate in it. The memory of water has been studied quite a lot. The estimate of the duration of this memory has been revised 2 downwards from a few picoseconds to approximately 50 femtoseconds (50 ϫ 10 -15 s). That is not a very good shelf life. It is one thing to tolerate homeopathy as a harmless 19th century eccentricity for its placebo effect in minor self-limiting conditions like colds. It is quite another to have it recommended for seriously ill patients. That is downright dangerous.
David Colquhoun, FRS University College of London London,UK
The author has no conflicts of interest to disclose. Reproduction of this article is prohibited without written permission
Response
We want to thank Dr. Colquhoun for his interest in our study. 1 First, the terms used should be defined precisely. Homeopathy is a science based on applied toxicology. Using digitalis either as a conventional or as a homeopathic physician makes no difference; both rely on observations (William Withering 1785) from pharmacology or on homeopathic proof. We are happy that toxicology as well as homeopathic proof have been shown to be reliable and consistent for centuries.
Before I refer to the dilutions beyond the Loschmidt number, it is important to state that homeopathy doses that are equivalent to those of conventional medicine can be administered without any dilution. However, toxic effects should be avoided. If one refuses to use potencies beyond this number, they should simply not be used. Since Dr. Colquhoun assumes that high potencies exhibit no effect at all, then we cannot understand why it should be dangerous to treat critically ill patients additively if there is "nothing" in it. We are also concerned that Dr. Colquhoun questions the value of randomized controlled trials. This opinion appears to be inconsistent with the current position of conventional science.
It is correct that "the medicine contains no medicine"; however, "ultrafast memory loss" in the hydrogen bond network of liquid H 2 O implies that at least some sort of memory exists. However, contrary to the study cited, 2 potentized drugs are not stored in water, but in an alcohol-water mixture.
I invite Dr. Colquhoun to join our efforts in studying the effects of high potencies on physical properties. We are always open to tolerant, academic-driven scientific cooperation. Let us make a common effort to reveal the riddle for the sake of millions of patients by supporting the Institute for Homeopathic Research, at Interuniversity College. 
